drugset / Trial / NCT01316042
Metformin for the Treatment of Premature Pubarche in Girls
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of this study is to determine the safety and efficacy of metformin in lowering serum DHEAS levels in girls with premature pubarche and secondary, to observe changes in hormones associated with pubertal development including gonadotropins, sex steroids, insulin, adipocytokines, and growth factors.
Timeline
- Start
- 2011-05
- Primary completion
- 2013-12
- Completion
- 2014-04
Outcome
Outcome not reported
Stopped (Enrollment): “poor recruitment at collaborating sites”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metformin | Small molecule | 212.5 mg | — |